These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 15302513

  • 21. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M, Yoshimura R, Mitsuhashi M, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
    [Abstract] [Full Text] [Related]

  • 22. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y.
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
    [Abstract] [Full Text] [Related]

  • 23. [Ki-67 antisense therapy in murine renal cell carcinoma models].
    Kausch I, Jiang H, Brocks C, Albers A, Krüger S, Sczakiel G, Jocham D.
    Aktuelle Urol; 2005 Apr; 36(2):142-8. PubMed ID: 15902575
    [Abstract] [Full Text] [Related]

  • 24. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy.
    Sourbier C, Danilin S, Lindner V, Steger J, Rothhut S, Meyer N, Jacqmin D, Helwig JJ, Lang H, Massfelder T.
    Cancer Res; 2007 Dec 15; 67(24):11668-76. PubMed ID: 18089796
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.
    Nishikawa T, Akiyama N, Kunimasa K, Oikawa T, Ishizuka M, Tsujimoto M, Natori S.
    Eur J Pharmacol; 2006 Jun 13; 539(3):151-7. PubMed ID: 16725138
    [Abstract] [Full Text] [Related]

  • 26. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5124-30. PubMed ID: 18698030
    [Abstract] [Full Text] [Related]

  • 27. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
    Nakanishi H, Mizutani Y, Kawauchi A, Ukimura O, Shiraishi T, Hatano M, Mizuno M, Yoshida J, Miki T.
    Clin Cancer Res; 2003 Mar 15; 9(3):1129-35. PubMed ID: 12631618
    [Abstract] [Full Text] [Related]

  • 28. In vivo and in vitro effect of baicalein on human prostate cancer cells.
    Miocinovic R, McCabe NP, Keck RW, Jankun J, Hampton JA, Selman SH.
    Int J Oncol; 2005 Jan 15; 26(1):241-6. PubMed ID: 15586246
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
    Landen CN, Lu C, Han LY, Coffman KT, Bruckheimer E, Halder J, Mangala LS, Merritt WM, Lin YG, Gao C, Schmandt R, Kamat AA, Li Y, Thaker P, Gershenson DM, Parikh NU, Gallick GE, Kinch MS, Sood AK.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1558-70. PubMed ID: 17077358
    [Abstract] [Full Text] [Related]

  • 30. [Antitumor effect and mechanism of shikonin derivative SYUNZ-7].
    Huang H, Xie BF, Zhu XF, Feng GK, Zhou JM, Wang Y, Wu HQ, Huang ZS, Gu LQ, Liu ZC.
    Ai Zheng; 2005 Dec 01; 24(12):1453-8. PubMed ID: 16351791
    [Abstract] [Full Text] [Related]

  • 31. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide.
    Cao QZ, Lin ZB.
    Acta Pharmacol Sin; 2004 Jun 01; 25(6):833-8. PubMed ID: 15169641
    [Abstract] [Full Text] [Related]

  • 32. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
    Hsu SC, Ou CC, Chuang TC, Li JW, Lee YJ, Wang V, Liu JY, Chen CS, Lin SC, Kao MC.
    Cancer Lett; 2009 Aug 18; 281(1):108-16. PubMed ID: 19332363
    [Abstract] [Full Text] [Related]

  • 33. Antitumor and antiangiogenic activity of soy phytoestrogen on 7,12-dimethylbenz[alpha]anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats.
    Kang X, Jin S, Zhang Q.
    J Food Sci; 2009 Sep 18; 74(7):H237-42. PubMed ID: 19895476
    [Abstract] [Full Text] [Related]

  • 34. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.
    Marimpietri D, Brignole C, Nico B, Pastorino F, Pezzolo A, Piccardi F, Cilli M, Di Paolo D, Pagnan G, Longo L, Perri P, Ribatti D, Ponzoni M.
    Clin Cancer Res; 2007 Jul 01; 13(13):3977-88. PubMed ID: 17606732
    [Abstract] [Full Text] [Related]

  • 35. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
    Yalcin M, Bharali DJ, Lansing L, Dyskin E, Mousa SS, Hercbergs A, Davis FB, Davis PJ, Mousa SA.
    Anticancer Res; 2009 Oct 01; 29(10):3825-31. PubMed ID: 19846915
    [Abstract] [Full Text] [Related]

  • 36. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo.
    Talon I, Lindner V, Sourbier C, Schordan E, Rothhut S, Barthelmebs M, Lang H, Helwig JJ, Massfelder T.
    Carcinogenesis; 2006 Jan 01; 27(1):73-83. PubMed ID: 16081513
    [Abstract] [Full Text] [Related]

  • 37. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y.
    Phytother Res; 2008 Aug 01; 22(8):1125-32. PubMed ID: 18570244
    [Abstract] [Full Text] [Related]

  • 38. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel.
    Shang D, Ito N, Kamoto T, Ogawa O.
    Urology; 2007 May 01; 69(5):1007-12. PubMed ID: 17482960
    [Abstract] [Full Text] [Related]

  • 39. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M.
    Oncol Rep; 2007 Oct 01; 18(4):801-9. PubMed ID: 17786339
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522.
    Sato N, Mizutani Y, Li YN, Fujiwara J, Ishida H, Toiyama D, Abe K, Hayashi I, Nakanishi H, Kawauchi A, Miki T.
    Urol Int; 2010 Oct 01; 84(3):362-8. PubMed ID: 20389170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.